The Effects of Glycine Therapy on the Fetal Outcome of Diabetic Mice

Elizdath Martínez, Alberto García, Angel Saenz, Leticia Garduño, María Salazar, Germán Chamorro

Research output: Contribution to journalArticlepeer-review

3 Scopus citations

Abstract

The effect of glycine in preventing diabetes teratogenicity was studied in mice. Pregnant female animals were given an IP injection of 200mg/kg of streptozotocin (STZ) on gestation day (GD) 7. Glycine was administered ad libitum from GD9 through GD19 (day of sacrifice) as a 1 and 2% drinking water solution. Nine whole-litter resorptions, a decreased number of live fetuses and fetal parameters, and an increase in HbA1C levels in diabetic dams were found. Malformations were limited. Glycine had a protective effect from hemoglobin glycation and embryotoxicity due to STZ-induced diabetes. Also, resorptions and malformed fetuses were positively correlated to HbA 1C levels with a negative correlation to the number of live fetuses. The data suggest that glycine reduces the embryolethality of STZ-induced diabetes due to its anti-glycation effect.

Original languageEnglish
Pages (from-to)449-453
Number of pages5
JournalPharmaceutical Biology
Volume41
Issue number6
DOIs
StatePublished - Sep 2003

Keywords

  • Diabetes
  • Embryotoxicity
  • Glycation
  • Glycine
  • Teratogenesis

Fingerprint

Dive into the research topics of 'The Effects of Glycine Therapy on the Fetal Outcome of Diabetic Mice'. Together they form a unique fingerprint.

Cite this